Impact of a Medication Review on Hospital Readmission: (ConcReHosp)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

470 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-07-01

Study Completion Date

2019-03-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study is a randomized controlled clinical trial. A total 1400 hospitalized patients will be randomized in two groups:

1. group receiving a pharmacist-led standardized medication review (experimental group); and
2. group not receiving the medication review (control group).

The patients will be followed up at 30 days after initial hospitalization. Outcome measures include the number of readmissions; patient satisfaction, quality of medical admission prescription and number of consultation after initial hospitalization.

Discussion: A randomized controlled trial will provide the highest level of evidence on the impact of pharmacist-led standardized medication review on early hospital readmission for extreme age population.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Impact of Pharmacist Post-discharge Phone Calls on Hospital Readmission and Patient Medication Literacy and Adherence

NCT02031406

Medication Adherence & Literacy to Predict Readmission Post-discharge Pharmacist Counseling to Prevent Readmissions

TERMINATED NA

Medication Reconciliation Process in Clinical Practice

NCT07001137

Medication Reconciliation Patient Safety Geriatrics +3 more

COMPLETED

Communication Between Hospital and Community Pharmacists: Impact on Drug Management at Discharge

NCT02006797

Treatment Error

UNKNOWN NA

Comprehensive Management of Drug Prescriptions Throughout the Elderly Person's Hospital Care

NCT03666793

Elderly Medication Reconciliation Patient Readmission

COMPLETED NA

Therapeutic Optimization in Patients in Acute Geriatric Care at University Hospital of Montpellier

NCT04223921

Geriatrics Clinical Pharmacy

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The impact of Medication Reconciliation on the early hospital readmission in the elderly is not clearly demonstrated. Moreover, the impact of medication reconciliation in the pediatric population is poorly studied.

In such context, it is important to demonstrate the effectiveness of the medication reconciliation as part of a standardized medication review process, in pediatric and in the elderly, on all cause readmissions in a large randomized control clinical trial. The standardized medication review process includes medication reconciliation, treatment review and medication liaison service.

The main objective of this study is to assess the impact of the standardized medication review on the rate of readmissions and/or death at 30 days following initial hospitalization discharge.

Methods/design: The study is a randomized controlled clinical trial. A total 1400 hospitalized patients will be randomized in two groups:

1. group receiving a pharmacist-led standardized medication review (experimental group); and
2. group not receiving the medication review (control group).

The patients will be followed up at 30 days after initial hospitalization. Outcome measures include the number of readmissions; patient satisfaction, quality of medical admission prescription and number of consultation after initial hospitalization.

Discussion: A randomized controlled trial will provide the highest level of evidence on the impact of pharmacist-led standardized medication review.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Re-hospitalization

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

standard course

group not receiving medication review

Group Type OTHER

pharmacist-led standardized medication review

Intervention Type OTHER

the goal of this study is to assess the impact of the standardized medication review on the rate of readmissions and/or death at 30 days following initial hospitalization discharge.

pharmacist-led standardized medication review

pharmacist-led standardized medication review including :

* Medical and pharmaceutical admission medication reconciliation and treatment review
* Medical and pharmaceutical medication reconciliation at discharge and treatment review
* Medication Liaison Service

Group Type OTHER

pharmacist-led standardized medication review

Intervention Type OTHER

the goal of this study is to assess the impact of the standardized medication review on the rate of readmissions and/or death at 30 days following initial hospitalization discharge.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

pharmacist-led standardized medication review

the goal of this study is to assess the impact of the standardized medication review on the rate of readmissions and/or death at 30 days following initial hospitalization discharge.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects aged under 18 or over 65 years
* Subject hospitalized in the multidisciplinary pediatric service or internal medicine ward, after emergency department visit at Timone hospital (Marseille, France) regardless of the reason for admission
* Subject with or without any comorbidity
* Living in France
* With national publicly-founded health insurance

* Major subject and/or holder of parental authority of a hospitalized child, who fulfills the eligibility criteria mentioned above, in the multidisciplinary pediatric ward;
* Whatever the reason for hospitalization of the patient;

* Major subject, designated by the patient or designating himself as the person most involved in the daily life of the patient;
* Whatever the reason for hospitalization of the patient;
* Whatever relationship or proximity to the study patient (family member, friend, neighbor);

Exclusion Criteria

* Patients whose care requires regular re-hospitalization / programmed less than 30 days after discharge of initial hospitalization
* Vulnerable persons according to French law (pregnant women, adults under guardianship, persons deprived of liberty)

Eligible Sex

ALL

Accepts Healthy Volunteers

No